Braveheart Bio | $185,000,000 | (Nov 6, 2025)
CommanderAI | $5,000,000 | (Nov 6, 2025)
Procurement Sciences | $30,000,000 | (Nov 6, 2025)
Certified by Founder
Lodge
Moonwalk Biosciences
start up
United States
- South San Francisco, California
- 08/01/2024
- Series A
- $57,000,000
Moonwalk Biosciences is an early-stage therapeutics company co-founded by Dr. Feng Zhang and leading experts in cell state epigenetics including Alex Aravanis, the former CTO of Illumina. The company has developed a differentiated approach to mapping the epigenome of cellular states at the whole genome, single cell resolution level, as well as proprietary strategies for precise epigenetic engineering. The combination enables both a novel discovery platform and a path to developing therapeutics that include both epigenetic engineering and other traditional modalities.
- Industry Biotechnology Research
- Website https://moonwalk.bio/
- LinkedIn https://www.linkedin.com/company/moonwalk-biosciences/about/
Freeda | $3,912,210 | (Nov 6, 2025)
NEOK Bio | $75,000,000 | (Nov 6, 2025)
LambdaVision, Inc. | $7,000,000 | (Nov 6, 2025)
Flux XII Inc. | $3,950,000 | (Nov 6, 2025)
Boostie | $500,000 | (Nov 6, 2025)
Rilevera | $3,000,000 | (Nov 6, 2025)
Wisconsin Alumni Research Foundation (WARF) | $3,950,000 | (Nov 6, 2025)
Cactus | $7,000,000 | (Nov 6, 2025)
GitLaw | $30,000,000 | (Nov 6, 2025)